|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 | |
| A61P 7/04 | |||
| A61K 38/48 |
| (11) | Patento numeris | 2414517 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10723842.0 |
| Europos patento paraiškos padavimo data | 2010-03-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/029064 |
| Data | 2010-03-29 |
| (87) | Numeris | WO 2010/117729 |
| Data | 2010-10-14 |
| (30) | Numeris | Data | Šalis |
| 164886 P | 2009-03-30 | US |
| (72) |
SINHA, Uma, US
LU, Genmin, US
CONLEY, Pamela B., US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (54) | ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME |
| ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME |